Lumos Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Lumos Pharma and buy or sell other stocks, ETFs, and their options commission-free!About LUMO
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD).
CEORichard J. Hawkins
CEORichard J. Hawkins
Employees—
Employees—
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1999
Founded1999
Employees—
Employees—
LUMO Key Statistics
Market cap37.53M
Market cap37.53M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume74.85K
Average volume74.85K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.58
52 Week high$4.58
52 Week low$1.37
52 Week low$1.37
Stock Snapshot
As of today, Lumos Pharma(LUMO) shares are valued at $4.34. The company's market cap stands at 37.53M, with a P/E ratio of -1.01.
During the trading day, Lumos Pharma(LUMO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 74.85K.
The stock's 52-week range extends from a low of $1.37 to a high of $4.58.
The stock's 52-week range extends from a low of $1.37 to a high of $4.58.
People also own
Based on the portfolios of people who own LUMO. This list is generated using Robinhood data, and it’s not a recommendation.